181 related articles for article (PubMed ID: 27321150)
1. Outcomes with image-based interstitial brachytherapy for vaginal cancer.
Manuel MM; Cho LP; Catalano PJ; Damato AL; Miyamoto DT; Tempany CM; Schmidt EJ; Viswanathan AN
Radiother Oncol; 2016 Sep; 120(3):486-492. PubMed ID: 27321150
[TBL] [Abstract][Full Text] [Related]
2. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
[TBL] [Abstract][Full Text] [Related]
3. Differences in urethral dosimetry between CT and MR imaging in multichannel vaginal cylinder brachytherapy.
Chen KS; Glaser SM; Kim H; Beriwal S
Brachytherapy; 2017; 16(5):964-967. PubMed ID: 28694115
[TBL] [Abstract][Full Text] [Related]
4. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
[TBL] [Abstract][Full Text] [Related]
5. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
6. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
Lee LJ; Damato AL; Viswanathan AN
Gynecol Oncol; 2013 Dec; 131(3):586-92. PubMed ID: 24029418
[TBL] [Abstract][Full Text] [Related]
8. 3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience.
Goodman CD; Mendez LC; Velker V; Weiss Y; Leung E; Louie AV; Warner A; Hajdok G; D'Souza DP
Gynecol Oncol; 2021 Jan; 160(1):134-139. PubMed ID: 33162177
[TBL] [Abstract][Full Text] [Related]
9. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
[TBL] [Abstract][Full Text] [Related]
10. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
Ling DC; Vargo JA; Glaser SM; Kim H; Beriwal S
Gynecol Oncol; 2019 Mar; 152(3):581-586. PubMed ID: 30600093
[TBL] [Abstract][Full Text] [Related]
12. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer.
Tait LM; Hoffman D; Benedict S; Valicenti R; Mayadev JS
Brachytherapy; 2016; 15(3):333-340. PubMed ID: 26882845
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract][Full Text] [Related]
14. Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.
Baek S; Isohashi F; Yamaguchi H; Mabuchi S; Yoshida K; Kotsuma T; Yamazaki H; Tanaka E; Sumida I; Tamari K; Otani K; Seo Y; Suzuki O; Yoshioka Y; Kimura T; Ogawa K
Brachytherapy; 2016; 15(6):812-816. PubMed ID: 27614661
[TBL] [Abstract][Full Text] [Related]
15. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
16. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy.
Kim H; Rajagopalan MS; Houser C; Beriwal S
Brachytherapy; 2014; 13(3):263-7. PubMed ID: 24080298
[TBL] [Abstract][Full Text] [Related]
18. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
19. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer.
Westerveld H; Nesvacil N; Fokdal L; Chargari C; Schmid MP; Milosevic M; Mahantshetty UM; Nout RA
Lancet Oncol; 2020 Mar; 21(3):e157-e167. PubMed ID: 32135119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]